Disagreement in the assessment of the HAVcr-1/KIM-1/TIM-1 expression in cancer tissues may be explained by different sensitivity of the immunochemical methods or unique epitope specificity of AKG7 antibody [59]. This evidence concerns the gene HAVCR1 and cancer.